Cambridge Cognition (COG) Competitors GBX 32 +1.50 (+4.92%) (As of 12/20/2024 09:50 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider Trades COG vs. RENX, INHC, IQAI, FDBK, DVRG, TRLS, SENS, EMIS, CRW, and INSShould you be buying Cambridge Cognition stock or one of its competitors? The main competitors of Cambridge Cognition include Renalytix (RENX), Induction Healthcare Group (INHC), IQ-AI (IQAI), Feedback (FDBK), DeepVerge (DVRG), Trellus Health (TRLS), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), and Instem (INS). These companies are all part of the "health information services" industry. Cambridge Cognition vs. Renalytix Induction Healthcare Group IQ-AI Feedback DeepVerge Trellus Health Sensyne Health EMIS Group Craneware Instem Renalytix (LON:RENX) and Cambridge Cognition (LON:COG) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, valuation, dividends, earnings, media sentiment, analyst recommendations, profitability, institutional ownership and risk. Does the MarketBeat Community favor RENX or COG? Cambridge Cognition received 82 more outperform votes than Renalytix when rated by MarketBeat users. However, 74.19% of users gave Renalytix an outperform vote while only 44.30% of users gave Cambridge Cognition an outperform vote. CompanyUnderperformOutperformRenalytixOutperform Votes2374.19% Underperform Votes825.81% Cambridge CognitionOutperform Votes10544.30% Underperform Votes13255.70% Do insiders and institutionals have more ownership in RENX or COG? 28.4% of Renalytix shares are owned by institutional investors. Comparatively, 35.2% of Cambridge Cognition shares are owned by institutional investors. 35.7% of Renalytix shares are owned by company insiders. Comparatively, 29.9% of Cambridge Cognition shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has better earnings & valuation, RENX or COG? Cambridge Cognition has higher revenue and earnings than Renalytix. Cambridge Cognition is trading at a lower price-to-earnings ratio than Renalytix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRenalytix£2.29M7.21-£33.46M-£0.24-41.46Cambridge Cognition£13.08M1.03-£1.32M-£0.04-800.00 Which has more volatility & risk, RENX or COG? Renalytix has a beta of 2.1, indicating that its share price is 110% more volatile than the S&P 500. Comparatively, Cambridge Cognition has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500. Is RENX or COG more profitable? Renalytix has a net margin of 0.00% compared to Cambridge Cognition's net margin of -10.07%. Cambridge Cognition's return on equity of -74.36% beat Renalytix's return on equity.Company Net Margins Return on Equity Return on Assets RenalytixN/A -1,073.18% -93.54% Cambridge Cognition -10.07%-74.36%-0.30% Does the media refer more to RENX or COG? In the previous week, Renalytix and Renalytix both had 2 articles in the media. Cambridge Cognition's average media sentiment score of 0.94 beat Renalytix's score of 0.49 indicating that Cambridge Cognition is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Renalytix 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cambridge Cognition 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryCambridge Cognition beats Renalytix on 8 of the 14 factors compared between the two stocks. Ad WealthPress70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.>> You can grab your FREE, laminated copies right here << Get Cambridge Cognition News Delivered to You Automatically Sign up to receive the latest news and ratings for COG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart COG vs. The Competition Export to ExcelMetricCambridge CognitionHealth Information Services IndustryMedical SectorLON ExchangeMarket Cap£13.42M£196.58M£5.14B£1.92BDividend YieldN/A6.94%5.09%5.45%P/E Ratio-800.00540.3889.971,880.82Price / Sales1.03285.021,116.34397,035.90Price / Cash4.3147.1443.1028.78Price / Book5.335.074.782.81Net Income-£1.32M-£8.11M£120.31M£156.11M7 Day Performance3.23%-0.95%-1.92%-2.03%1 Month Performance15.52%5.83%13.65%21.85%1 Year Performance-37.73%6.32%28.34%30.10% Cambridge Cognition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COGCambridge CognitionN/AGBX 32+4.9%N/A-37.9%£13.42M£13.08M-800.0080News CoverageGap DownHigh Trading VolumeRENXRenalytixN/AGBX 9.50flatN/A-28.9%£15.76M£2.29M-40.63102News CoverageINHCInduction Healthcare GroupN/AGBX 9-5.3%N/A-61.5%£8.45M£13.65M-300.0074Gap DownIQAIIQ-AIN/AGBX 1.47-2.0%N/A-63.0%£3.26M£538,190.00-13.676Gap UpFDBKFeedbackN/AGBX 17.75flatN/A-75.9%£2.37M£1.18M-71.0024Gap DownDVRGDeepVergeN/AGBX 0.15flatN/AN/A£1.14M£12.41M-15.0073TRLSTrellus HealthN/AGBX 0.58-8.0%N/A-82.9%£929,000.00£35,000.00-20.0031Gap DownHigh Trading VolumeSENSSensyne HealthN/AGBX 0.35-33.3%N/AN/A£583,000.00£7.81M-0.0270Gap DownEMISEMIS GroupN/AN/AN/AN/A£1.23B£176.86M4,085.111,560CRWCraneware1.4332 of 5 starsGBX 2,300-1.7%GBX 2,700+17.4%+22.9%£812.82M£189.27M9,192.31734INSInstemN/AGBX 830flatN/AN/A£199.62M£61.63M5,928.57500News Coverage Related Companies and Tools Related Companies Renalytix Competitors Induction Healthcare Group Competitors IQ-AI Competitors Feedback Competitors DeepVerge Competitors Trellus Health Competitors Sensyne Health Competitors EMIS Group Competitors Craneware Competitors Instem Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:COG) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cambridge Cognition Holdings Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cambridge Cognition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free COG Stock Alerts